Justin Farlow

Justin Farlow is the cofounder and Chief Technology Officer (CTO) of Serotiny, a biotechnology firm focused on revolutionizing gene design, particularly for multi-domain proteins. Holding a PhD, Farlow’s expertise has significantly contributed to the development of Serotiny’s innovative technology. He is motivated by the potential of gene and cell therapies to treat diseases, aiming to leverage Serotiny’s technology for therapeutic applications. His work is instrumental in advancing the field of genetic engineering, aligning with the broader goal of creating effective treatments for various health conditions.